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Abstract
Serum N-acetyl-b-D-glucosaminidase (NAG; EC
3.2.1.30) is a hexosaminidase and may be a predictor
of vascular injury, e.g., in infant respiratory distress
syndrome, pneumonia, broncho-pulmonary dysplasia
and necrotizing enterocolitis. To estimate the new
diagnostic prospects we have modified our urinary
NAG assay. In this sensitive colorimetric micro-assay,
VRA-GlcNAc was used as a substrate. In the present
study the age dependence of serum NAG activity was
investigated in newborn babies, infants (1–
24 months), children (2–18 years) and adults (19–
80 years). Serum NAG activity was found to be
age-dependent; it is higher in early childhood (11–
59 U/l) but decreases to a constant value at the age
of 1–2 years. After the age of 2 years it is similar to
adults’ NAG (10–30 U/l). In pediatrics age-matched
reference ranges must be taken into consideration.
Keywords: age dependence; infant respiratory dis-
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Lysosomal hexosaminidases such as N-acetyl-b-D-
glucosaminidase (NAG, EC 3.2.1.30) exist in a number
of tissues (liver, kidney, spleen and bowel). After tis-
sue damage they might be released into the circula-
tion. In the last decades NAG isoenzymes were used
mainly for screening Tay-Sachs disease (TSD) (1, 2).
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For the previous tests generally plasma or serum is
used (2–5), while to detect tubulopathy a urinary sam-
ple is used (6–11). Serum NAG may be a possible pre-
dictor of vascular injury in diabetes mellitus and
hypertension (12, 13). Although hexosaminidase
activity varies during postnatal development and
depends on feeding, serum NAG has been proposed
recently as a predictor of infant respiratory distress
syndrome (IRDS), broncho-pulmonary dysplasia
(BPD) and pneumonia in premature babies (3).
Increase in serum NAG has also been suggested as
a marker for the early identification of necrotizing
enterocolitis (NEC) (14). NAG activity might be deter-
mined by fluorometric methods (15), although colori-
metric assays present many advantages (16).
Our aim was to examine the age dependence of
serum NAG. Because of the limited volume of serum,
the urinary NAG assay (8–10) was modified. This
resulted in a simple and sensitive micro-method,
which is applicable to different clinical areas. The Kol-
mogorov-Smirnov test was used to test the normality
of distributions, both for NAG enzyme activities and
their logarithms. Age dependence was tested using
one-way analysis of variance (ANOVA). Dunnet’s test
was used to compare multiple age groups to the adult
group. No significant difference was found in enzyme
activities between males and females. NAG activities
showed a rather large scatter in newborns, with a dis-
tribution not significantly different from Gaussian. In
all other age groups NAG activities were log-normally
distributed (Kolmogorov-Smirnov test, p)0.05). With
ANOVA we found that NAG is age dependent. As indi-
cated by Dunnet’s test, NAG is significantly higher
below 2 years of age than in adults, and then falls to
the adult value. The reference ranges (95% confidence
level) are shown in Table 1.
Decreased activity of serum total NAG and isoen-
zyme A is well known in TSD patients (1, 2). In con-
trast, the potential value of increased serum NAG in
newborns with IRDS, BPD (3) and NEC (14) was con-
firmed. Very limited data can be found for serum hex-
osaminidase in newborns and premature babies (4,
14). Our NAG results are similar to the values pub-
lished earlier (3, 4, 14). In accordance with our results,
Lobe et al. (14) showed that NAG activity is independ-
ent of sex and is relatively high during the first
3 weeks of life. As they have found higher NAG values
after the onset of NEC, or pneumonia, we plan to
check whether NAG could be an early detector for
these inflammatory diseases. Similarly to our new-
borns’ range, Shattuck et al. described increased NAG
activity in premature babies at the 1st–8th weeks of
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Table 1 Reference ranges of serum NAG isoenzyme activities in various age groups.
Age groups Newborns Infants Children Adults
-1 month, 1–24 months, 2–18 years, 19–80 years,
ns22 ns25 ns24 ns23
NAG enzyme Lower limit 11.0 11.5 10.4 10.0
activity (U/l) Upper limit 48.1 59.3 28.5 30.0
Serum NAG assay (10): 3.3 mmol/l VRA-Glc-NAc substrate (PPR Diagnostics, London, E1W 1AT, UK) was dissolved in citric
acid-disodium hydrogen phosphate buffer (0.15 mol/l, pH 4.8) and pre-incubated at 378C for 5 min. Before the enzyme assay,
25 ml of serum was diluted with 25 ml of the same buffer to decrease the inhibiting effect of urea (17). To 350 ml of substrate
solution, 25 ml diluted serum was added and incubated for 30 min at 378C. The reaction was stopped with 375 ml potassium
hydrogen carbonate-dipotassium carbonate buffer (1.2 mol/l; pH 9.8) and the absorbance (A) was read at 505 nm against the
reagent blank in a 1 cm cuvette (Humalyser 2000, Human, Germany). Serum samples were stored at y208C for 1–4 weeks.
NAG activity was calculated directly via specific molar absorbance: NAG activity (U/l) s A(505)=28.5=2.
life (4). Recently it was suggested that NAG might be
a marker of oxidative stress, e.g., in diabetic micro-
angiopathy, as it correlates with plasma malondial-
dehyde in diabetes mellitus type 2 (18). Although
serum NAG is not a specific marker for vascular dis-
eases, it may contribute to the early diagnosis of the
diseases mentioned above.
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